Afortiori Bio is a preclinical stage RNA therapeutics company founded by experts in the discovery and development of commercial medicines.

The business is driven by scienctific excellence and an unwavering commitment to accelerating product development, paving the way for a paradigm shift in the treatment of chronic liver disease.

Their pioneering approach to developing innovative RNA medicines addresses critical unmet need to transform lives.